At a glance
ClinicalIndex Comparison RecordN/ACompleted· 95 enrolled
Drug / intervention
Tactile Imaging (VerTouch) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, Parallel, Randomized Study to Evaluate the Performance of Needle Placements for Diagnostic and Therapeutic Neuraxial Procedures, Using a Handheld Tactile Imaging-based Method Versus Palpation
In Brief
A clinical study evaluating Tactile Imaging (VerTouch) and Control (palpation) for Central Nervous System Infections and 6 related conditions. Completed, enrolled 95 participants across 3 sites.
Detailed Summary
This study will compare the VerTouch device to the conventional palpation technique for performing diagnostic and therapeutic neuraxial procedures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCentral Nervous System Infections, Pseudotumor Cerebri, Neurological Disorder, Cancer, Obstetric Procedure Pain, Orthopedic Procedure Pain, Post-Dural Puncture Headache
CountriesUnited States
CollaboratorsICON plc
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMar 2021
Enrollment StartApr 2021
Primary CompletionNov 2021
TodayJul 2026
First PostedMar 15, 2021
Enrollment StartApr 4, 2021
Primary CompletionNov 24, 2021
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 5.3 years ago
Interventions
Tactile Imaging (VerTouch)device
VerTouch device used to identify and mark, or begin placement of a needle at an insertion site. After the device is taken off the back, the procedure will continue in the usual manner.
Control (palpation)other
Control, palpation used to identify and mark an insertion site.